|4May 13, 11:28 AM ET

Chang Glenn 4

4 · iBio, Inc. · Filed May 13, 2019

Insider Transaction Report

Form 4
Period: 2019-02-20
Chang Glenn
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-206,00036,750 total
    Exercise: $6.60Exp: 2019-08-10Common Stock (6,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+2,25036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (2,250 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+4,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (4,500 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+4,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (4,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-203,00036,750 total
    Exercise: $17.30Exp: 2020-08-16Common Stock (3,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+4,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (4,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-206,00036,750 total
    Exercise: $4.90Exp: 2024-09-05Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-2010,00036,750 total
    Exercise: $17.20Exp: 2025-09-04Common Stock (10,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+7,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-206,00036,750 total
    Exercise: $19.60Exp: 2021-10-21Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-206,00036,570 total
    Exercise: $11.00Exp: 2022-07-24Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-206,00036,750 total
    Exercise: $5.00Exp: 2023-07-16Common Stock (6,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+4,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (4,500 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+4,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (4,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-02-206,00036,750 total
    Exercise: $4.00Exp: 2027-05-01Common Stock (6,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-20+4,50036,750 total
    Exercise: $0.93Exp: 2024-02-20Common Stock (4,500 underlying)
Footnotes (5)
  • [F1]Vested in three equal annual instalments on the anniversary of the date of grant.
  • [F2]On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.
  • [F3]Reflects number of securities beneficially owned following all transactions reported on this Form 4.
  • [F4]Fully vests on first anniversary of grant date.
  • [F5]On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

Documents

1 file
  • 4
    doc4_6060.xmlPrimary

    PRIMARY DOCUMENT